These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 11605165)

  • 1. Sickle cell disease: current clinical management.
    Ballas SK
    Semin Hematol; 2001 Oct; 38(4):307-14. PubMed ID: 11605165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sickle cell anaemia: progress in pathogenesis and treatment.
    Ballas SK
    Drugs; 2002; 62(8):1143-72. PubMed ID: 12010077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sickle cell disease: clinical management.
    Ballas SK
    Baillieres Clin Haematol; 1998 Mar; 11(1):185-214. PubMed ID: 10872478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sickle cell disease: Classification of clinical complications and approaches to preventive and therapeutic management.
    Ballas SK
    Clin Hemorheol Microcirc; 2018; 68(2-3):105-128. PubMed ID: 29614627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent treatment guidelines for managing adult patients with sickle cell disease: challenges in access to care, social issues, and adherence.
    Adams-Graves P; Bronte-Jordan L
    Expert Rev Hematol; 2016 Jun; 9(6):541-52. PubMed ID: 27098013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sickle cell disease: a review for the internist.
    Pinto VM; Balocco M; Quintino S; Forni GL
    Intern Emerg Med; 2019 Oct; 14(7):1051-1064. PubMed ID: 31385153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of painful vaso-occlusive crisis of sickle-cell anemia: consensus opinion.
    Mousa SA; Al Momen A; Al Sayegh F; Al Jaouni S; Nasrullah Z; Al Saeed H; Alabdullatif A; Al Sayegh M; Al Zahrani H; Hegazi M; Al Mohamadi A; Alsulaiman A; Omer A; Al Kindi S; Tarawa A; Al Othman F; Qari M
    Clin Appl Thromb Hemost; 2010 Aug; 16(4):365-76. PubMed ID: 20530056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emergency Medicine Management of Sickle Cell Disease Complications: An Evidence-Based Update.
    Simon E; Long B; Koyfman A
    J Emerg Med; 2016 Oct; 51(4):370-381. PubMed ID: 27553919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current knowledge in the management of children and adolescents with sickle cell disease: Part 1, Physiological issues.
    Simon K; Lobo ML; Jackson S
    J Pediatr Nurs; 1999 Oct; 14(5):281-95. PubMed ID: 10554441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A brief review of the pathophysiology, associated pain, and psychosocial issues in sickle cell disease.
    Edwards CL; Scales MT; Loughlin C; Bennett GG; Harris-Peterson S; De Castro LM; Whitworth E; Abrams M; Feliu M; Johnson S; Wood M; Harrison O; Killough A
    Int J Behav Med; 2005; 12(3):171-9. PubMed ID: 16083320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The management of sickle cell pain.
    Richard RE
    Curr Pain Headache Rep; 2009 Aug; 13(4):295-7. PubMed ID: 19586593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A primary care provider's guide to preventive and acute care management of adults and children with sickle cell disease.
    Pack-Mabien A; Haynes J
    J Am Acad Nurse Pract; 2009 May; 21(5):250-7. PubMed ID: 19432908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuropathic Pain and Sickle Cell Disease: a Review of Pharmacologic Management.
    Orhurhu MS; Chu R; Claus L; Roberts J; Salisu B; Urits I; Orhurhu E; Viswanath O; Kaye AD; Kaye AJ; Orhurhu V
    Curr Pain Headache Rep; 2020 Jul; 24(9):52. PubMed ID: 32705357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sickle cell disease; a general overview.
    Schnog JB; Duits AJ; Muskiet FA; ten Cate H; Rojer RA; Brandjes DP
    Neth J Med; 2004 Nov; 62(10):364-74. PubMed ID: 15683091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypoxemia in sickle cell disease: significance and management.
    Caboot JB; Allen JL
    Paediatr Respir Rev; 2014 Mar; 15(1):17-23. PubMed ID: 24461342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A biopsychosocial model for the management of patients with sickle-cell disease transitioning to adult medical care.
    Crosby LE; Quinn CT; Kalinyak KA
    Adv Ther; 2015 Apr; 32(4):293-305. PubMed ID: 25832469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of a dedicated day hospital for management of acute sickle cell pain.
    Adewoye AH; Nolan V; McMahon L; Ma Q; Steinberg MH
    Haematologica; 2007 Jun; 92(6):854-5. PubMed ID: 17550862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psychosocial and pharmacological management of pain in pediatric sickle cell disease.
    Hildenbrand AK; Nicholls EG; Daly BP; Marsac ML; Tarazi R; Deepti R
    Postgrad Med; 2014 Mar; 126(2):123-33. PubMed ID: 24685976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nursing management of children with sickle cell disease: an update.
    Gribbons D; Zahr LK; Opas SR
    J Pediatr Nurs; 1995 Aug; 10(4):232-42. PubMed ID: 7562380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxidative stress in sickle cell disease; pathophysiology and potential implications for disease management.
    Nur E; Biemond BJ; Otten HM; Brandjes DP; Schnog JJ;
    Am J Hematol; 2011 Jun; 86(6):484-9. PubMed ID: 21544855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.